M. Madsen

发表

Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal.

O. Petersen, P. Briand, K. Nielsen, 1996, Cancer research.

Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.

M. Madsen, U. Jensen, C. Johansen, 2006, The Journal of investigative dermatology.

Level by MAPK-Activated Protein Kinase 2 Skin Is Regulated at a Posttranscriptional in Psoriatic a Protein Expression of TNF-Lars

M. Madsen, U. Jensen, C. Johansen, 2006 .

The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1.

P. Briand, M. Madsen, A. Lykkesfeldt, 1998, Cancer research.

Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells.

P. Briand, M. Madsen, A. Lykkesfeldt, 1997, Cancer research.

Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line

M. Madsen, A. Lykkesfeldt, B. Reiter, 1995, Molecular and Cellular Endocrinology.

Sensitivity to growth suppression by 1α,25-dihydroxyvitamin D3 among MCF-7 clones correlates with Vitamin D receptor protein induction

J. Bartek, J. Lukas, M. Madsen, 2002, The Journal of Steroid Biochemistry and Molecular Biology.

Altered Gene Expression of c-myc, Epidermal Growth Factor Receptor, Transforming Growth Factor-Â«,and c-erb-B2 in an Immortalized Human Breast Epithelial Cell Line, HMT-3522, Is Associated with Decreased Growth Factor Requirements1

P. Briand, K. Nielsen, M. Madsen, 2006 .

Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA

O. Petersen, P. Briand, M. Madsen, 1996, Molecular and Cellular Endocrinology.

Molecular aberrations in the MHC class I‐restricted pathway for antigen presentation in methylcholanthrene sarcomas from nude mice: discrepancies between MHC mRNA and surface protein

I. Svane, M. Madsen, M. Pedersen, 1997, Clinical and experimental immunology.

AmpliTaq Gold DNA Polymerase The Most Referenced Brand of DNA Polymerase in the World Date : 2005-05

J. J. Breen, Minetta C. Liu, M. Madsen, 2005 .

Resistance of human breast‐cancer cells to the pure steroidal anti‐estrogen ICI 182,780 is not associated with a general loss of estrogen‐receptor expression or lack of estrogen responsiveness

M. Madsen, A. Lykkesfeldt, S. Larsen, 1997, International journal of cancer.

Down-regulation of laminin-binding integrins by 1 alpha,25-dihydroxyvitamin D3 in human melanoma cells in vitro.

M. Madsen, C. M. Hansen, T. Skak-Nielsen, 1998, Cell adhesion and communication.

Growth factor requirement, oncogene expression and TP53 mutations of a tumorigenic and a non-tumorigenic subline of the human breast carcinoma cell line, HMT-3909.

P. Briand, M. Madsen, C. Theillet, 1995, European journal of cancer.

Protein Expression of TNF-α in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 21

M. Madsen, U. Jensen, C. Johansen, 2006, The Journal of Immunology.

MCF‐7/VDR: A new vitamin D resistant cell line

M. Madsen, C. M. Hansen, G. Pirianov, 2001, Journal of cellular biochemistry.

In vitro karyotype evolution and cytogenetic instability in the non-tumorigenic human breast epithelial cell line HMT-3522.

P. Briand, K. Nielsen, M. Madsen, 1994, Cancer genetics and cytogenetics.

Estradiol down regulates expression of vasoactive intestinal polypeptide receptor type-1 in breast cancer cell lines

M. Madsen, J. Fahrenkrug, B. Georg, 2001, Molecular and Cellular Endocrinology.

Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.

P. Briand, K. Nielsen, M. Madsen, 1992, Cancer research.

Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.

P. Briand, M. Madsen, A. Lykkesfeldt, 1994, Cancer research.

Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium.

O. Petersen, P. Briand, B. Deurs, 1990, Cancer research.

Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: Validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single‐locus fluorescence in situ hybridization

L. Bolund, P. Briand, M. Madsen, 1997, Genes, chromosomes & cancer.

Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.

J. Bartek, J. Lukas, M. Madsen, 2001, Molecular endocrinology.

Anticancer agent CHS 828 suppresses nuclear factor‐κB activity in cancer cells through downregulation of IKK activity

M. Madsen, L. Binderup, R. Larsson, 2004, International Journal of Cancer.

Downregulation of VPAC1R Expression in Breast Cancer Cell Lines

M. Madsen, J. Fahrenkrug, B. Georg, 2000, Annals of the New York Academy of Sciences.

Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522.

P. Briand, M. Madsen, C. Theillet, 1994, Experimental cell research.

Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines.

P. Briand, M. Madsen, 1990, European journal of cancer.

Liposomal formulation of retinoids designed for enzyme triggered release.

M. Madsen, T. Andresen, G. Peters, 2010, Journal of medicinal chemistry.

Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties.

M. Madsen, T. Andresen, P. J. Pedersen, 2010, Bioorganic & medicinal chemistry letters.